
Advancing Equitable Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) Management Strategies in Managed Care
Overview
Pricing: Free for Members and Non-Members
Course Description
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) is a rare and progressive disease characterized by the misfolding of amyloid fibrils that aggregate and deposit locally in one specific area of the body or deposit systemically, affecting many tissues and organs. Although a rare disease, the estimated prevalence in the United States (U.S.) is 120,000 and growing as we better understand its clinical presentation and appropriate diagnostic methods. However, in the U.S., significant diagnostic gaps are evident among Black and Hispanic/Latinx communities with ATTR-CM.
As experts in all aspects of drug therapy, managed care pharmacists play a pivotal role in shaping patient outcomes, access to treatments, and drug utilization by leveraging evidence-based recommendations to design and implement pharmacy and drug-related medical benefits. This is especially necessary for rare diseases, like ATTR-CM, to optimize clinical and quality programs that meet patient care needs while simultaneously managing the economic burden and complexities of the health care system.
This session will dive into the key data from clinical trials for novel ATTR-CM treatments, the complexities of health disparities that affect this disease and key managed care considerations.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Recognize the clinical indicators for early screening and diagnosis of Transthyretin Cardiac Amyloidosis (ATTR-CM), particularly among a diverse population
- Identify the burden of health disparities in ATTR-CM disease management on health outcomes and access to care in the United States.
- Distinguish the clinical efficacy, safety, monitoring, and patient selection criteria for new and emerging disease-modifying treatment options for ATTR-CM
- Discuss managed care approaches to optimizing diagnosis and the referral process, health outcomes, and equitable access to care for managing ATTR-CM.
Commercial Support
This activity is supported by an independent medical education grant from BridgeBio Pharma, Inc.
Faculty
Laura R. Bobolts, PharmD, BCOP
SVP, Clinical Strategy and Growth
OncoHealth
Pompano Beach, FL
Melissa Pozotrigo, PharmD, BCOP
Senior Clinical Pharmacist
Oncohealth
Atlanta, GA
Susan Wojcicki, PharmD
Clinical Pharmacy Lead
Humana Pharmacy Solutions Clinical and Specialty Strategies
Louisville, KY
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Susan Wojcicki, PharmD, BCOP Faculty | Disclosed no relevant financial relationships. |
Melissa Pozotrigo, PharmD, BCOP Faculty | Disclosed no relevant financial relationships. |
Laura R. Bobolts, PharmD, BCOP Faculty | Steering Committee Member: Pfizer |
Amy Lugo, PharmD, BCPS, BC-ADM Reviewer | Disclosed no relevant financial relationships. |
Brittany V. Henry, PharmD, MBA Planner | Disclosed no relevant financial relationships. |
Accreditation
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN: 0233-0000-25-008-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: April 11, 2025 • Expiration Date: December 31, 2026
Activity Fee: Free for Members and Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2024. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPE
The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.